US Broker Ratings

Solventum Corporation (SOLV) Stock Analysis: Navigating a 6.43% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a dynamic player in the healthcare sector, is capturing investor attention with its expansive portfolio and a potential upside of 6.43% as indicated by recent analyst..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Potential 49.69% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, continues to capture investor interest with its promising pipeline and robust portfolio of therapies for rare diseases and medical..

DaVita Inc. (DVA) Stock Analysis: Examining Growth Potential Amidst a 26.78% Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, presents an intriguing case for individual investors seeking growth potential. With a market capitalization..

Exact Sciences Corporation (EXAS) Investor Outlook: Navigating a Promising 2.95% Upside Amid Robust Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector with a keen focus on diagnostics and research, continues to capture investor attention. With its market capitalization reaching..

Genmab A/S (GMAB) Stock Analysis: Unpacking a Promising 13% Upside Potential in Biotech

Genmab A/S (GMAB), a leading biotechnology company based in Denmark, has been capturing the attention of investors with its robust pipeline of antibody-based therapies targeting cancer and other diseases. With..

Waters Corporation (WAT) Stock Analysis: Evaluating Growth Potential in Diagnostics & Research

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.99 billion and a robust..

Haleon plc (HLN) Stock Analysis: Evaluating a 15.72% Potential Upside for the UK Healthcare Giant

As investors navigate the volatile waters of the healthcare sector, Haleon plc (NYSE: HLN) emerges as an intriguing player with a substantial market capitalization of $45.11 billion. Positioned within the..

United Therapeutics Corporation (UTHR) Stock Analysis: Insights into a Healthcare Innovator with 2.19% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $22.94 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Powerhouse with an 18.22% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. With a market capitalization of $11.23 billion, Revvity offers..

Boston Scientific Corporation (BSX) Investor Outlook: 31% Upside Potential Amid Robust Revenue Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices industry, presents a compelling investment opportunity with a notable 31.02% potential upside, according to analyst ratings. With a..

Veeva Systems Inc. (VEEV) Stock Analysis: A 38.96% Potential Upside Attracts Investors

Investors eyeing opportunities in the healthcare technology sector might find Veeva Systems Inc. (NYSE: VEEV) an intriguing prospect. As a cloud-based software provider specializing in solutions for the life sciences..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 4.61% Dividend Yield and Growth Outlook

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $111.23 billion, BMY has established..

Cencora, Inc. (COR) Stock Analysis: Exploring a 13.75% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, particularly in medical distribution, is capturing investor attention with a significant market cap of $66.16 billion. As the company..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Challenging Landscape with a 22% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is at a pivotal juncture as it navigates a challenging financial landscape. With a market capitalization of $9.96 billion,..

Novartis AG (NVS) Stock Analysis: Navigating a Stable Path Amidst Healthcare Giants

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, continues to draw investor attention with its robust market position and expansive pharmaceutical portfolio. Headquartered in Basel, Switzerland, Novartis..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Navigating a 14% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, stands out for investors seeking exposure to the pharmaceutical industry. With a market capitalization of $52.08 billion,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Discovering a 23.89% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is capturing investor attention with its robust growth potential and strategic position in the healthcare sector. With a market cap of $14.48 billion, this San..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Insulet Corporation (PODD) Stock Analysis: Robust Analyst Ratings Signal a Promising 30.87% Upside

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, focusing on innovative medical devices. With a market capitalization of $20.32 billion, the company is known for its..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Powerhouse with a Promising 3.99% Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a stalwart in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $49.49 billion, Cardinal Health..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds